FRA:UKJ (Australia)  
Opthea Ltd logo

Opthea Ltd

€ 0.58 (-0.85%) Jan 30
P/E:
At Loss
P/B:
4.88
Market Cap:
€ 250.26M ($ 272.58M)
Enterprise V:
€ 168.96M ($ 184.03M)
Volume:
-
Avg Vol (2M):
1.00K
Also Trade In:
Volume:
-
Market Cap €:
250.26M
Market Cap $:
272.58M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.00K
Enterprise Value €:
168.96M
Enterprise Value $:
184.03M
PB Ratio:
4.88

Business Description

Description
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.8
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.89
Distress
Grey
Safe
Beneish M-Score -6.08
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 79.09
9-Day RSI 71.48
14-Day RSI 63.76
6-1 Month Momentum % -33.33
12-1 Month Momentum % -13.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.97
Quick Ratio 4.97
Cash Ratio 3.71
Days Sales Outstanding 2207.92

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.2

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -108421.14
Net Margin % -104246.74
ROE % -102.08
ROA % -93.85
ROIC % -824.33
ROC (Joel Greenblatt) % -1437.51
ROCE % -106.14